#BEGIN_DRUGCARD DB04816

# AHFS_Codes:
Not Available

# ATC_Codes:
A06AB03

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Altan
Antrapurol
Bancon
Chrysazin
Chrysazine
Criasazin
Danivac
Dantron
Diaquone
Dionone
Dorbane
Dorbanex
Dorbantyl
Duolax
Istan
Istin
Istizin
LTAN
Laxanorm
Laxanthreen
Laxipur
Laxipurin
Neokutin s
Pastomin
Prugol
Roydan
Scatron d
Zwitsalax

# CAS_Registry_Number:
117-10-2

# ChEBI_ID:
3682

# Chemical_Formula:
C14H8O4

# Chemical_IUPAC_Name:
1,8-dihydroxy-9,10-dihydroanthracene-9,10-dione

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 14:07:41 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Withdrawn from the Canadian, US, and UK markets in 1998 due to genotoxicity.

# Dosage_Forms:
Not Available

# Drug_Category:
Cathartics
Mutagens

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Investigational
Small Molecule
Withdrawn

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Dantron

# HET_ID:
Not Available

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H

# InChI_Key:
InChIKey=QBPFLULOKWLNNW-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C10312

# KEGG_Drug_ID:
D07107

# LIMS_Drug_ID:
4816

# Mechanism_Of_Action:
Not Available

# Melting_Point:
193 Â°C

# Molecular_Weight_Avg:
240.2109

# Molecular_Weight_Mono:
240.042258744

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA449206

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.98

# Predicted_LogS:
-2.9

# Predicted_Water_Solubility:
3.05e-01 g/l

# Primary_Accession_No:
DB04816

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
2950

# PubChem_Substance_ID:
46509077

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC1=CC=CC2=C1C(=O)C1=C(C=CC=C1O)C2=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
1,8-Dihydroxyanthrachinon
1,8-Dihydroxyanthraquinone
1,8-dihydroxy-9,10-anthracenedione
1,8-dihydroxy-9,10-anthraquinone
1,8-dihydroxyanthra-9,10-quinone
Chrysazin
Danthron

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:44 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Danthron

# pKa_Isoelectric_Point:
Not Available

# Phase_1_Metabolizing_Enzyme_1_Gene_Name:
CYP1A2

# Phase_1_Metabolizing_Enzyme_1_ID:
4200

# Phase_1_Metabolizing_Enzyme_1_Name:
Cytochrome P450 1A2

# Phase_1_Metabolizing_Enzyme_1_Protein_Sequence:
>Cytochrome P450 1A2
MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKN
PHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDG
QSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELM
AGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFP
ILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGN
LIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLS
DRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPEL
WEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLE
FSVPPGVKVDLTPIYGLTMKHARCEHVQARRFSIN

# Phase_1_Metabolizing_Enzyme_1_SwissProt_ID:
P05177

#END_DRUGCARD DB04816
